Kenneth B. Kassler-Taub

Insider Reports History

Entity
Individual
Location
2445 Technology Forest Blvd., 11 Th Floor, The Woodlands, TX
Signature
/s/ Kenneth B. Kassler-Taub, M.D.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kenneth B. Kassler-Taub:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LEXICON PHARMACEUTICALS, INC. SVP, Regulatory & QA Common Stock 163K $426K $2.62 Feb 28, 2024 Direct
LEXICON PHARMACEUTICALS, INC. SVP, Regulatory & QA Restricted Stock Units 65.5K $172K $2.62 Feb 28, 2024 Direct
LEXICON PHARMACEUTICALS, INC. SVP, Regulatory & QA Stock Option (Right to Buy) 204K Feb 8, 2024 Direct

Insider Reports Filed by Kenneth B. Kassler-Taub

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LXRX LEXICON PHARMACEUTICALS, INC. Feb 28, 2024 7 -$63.8K 4 Feb 29, 2024 SVP, Regulatory & QA
LXRX LEXICON PHARMACEUTICALS, INC. Feb 8, 2024 2 $0 4 Feb 12, 2024 SVP, Regulatory & QA
LXRX LEXICON PHARMACEUTICALS, INC. Feb 28, 2023 7 -$41.5K 4 Mar 1, 2023 SVP, Regulatory & QA
LXRX LEXICON PHARMACEUTICALS, INC. Feb 9, 2023 2 $0 4 Feb 13, 2023 SVP, Regulatory & QA
LXRX LEXICON PHARMACEUTICALS, INC. Feb 28, 2022 7 -$37.7K 4 Feb 28, 2022 SVP, Regulatory & QA
LXRX LEXICON PHARMACEUTICALS, INC. Feb 10, 2022 2 $0 4 Feb 14, 2022 SVP, Regulatory & QA
LXRX LEXICON PHARMACEUTICALS, INC. Oct 1, 2021 0 $0 3 Oct 1, 2021 SVP, Regulatory & QA